Details of the Drug Combination

General Information of Drug Combination (ID: DCB0AAH)

• Drug Combination Name: Heparin + Triferic
• Indication: End Stage Renal Disease; Status: Phase 1 [1]
• Component Drugs:
  Heparin (DM4ZP3W): Small molecular drug
  Triferic (DMYKU23): N.A.

References

• [1] ClinicalTrials.gov (NCT04042324) A Study to Investigate the Effect of Triferic Plus Heparin Infusion Compared to Heparin Alone on Coagulation Parameters in Hemodialysis Patients
• [2] Heparin FDA Label
• [3] FDA Approved Drug Products from FDA Official Website. 2019. Application Number: (ANDA) 090809.
• [4] Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia. Emerg Microbes Infect. 2020 Dec;9(1):727-732.
• [5] Clinical pipeline report, company report or official report of Rockwell medical technologies.